Etaracizumab (LM 609) 是一种αvβ3整合素IgG1 单克隆抗体。Etaracizumab 抑制血管生成和黑色素瘤生长。Etaracizumab 可用于抗癌研究。
| 生物活性 | Etaracizumab (LM 609) is anαvβ3integrinIgG1monoclonal antibody. Etaracizumab inhibits angiogenesis and melanoma tumor growth. Etaracizumab can be used to research anticancer[1]. |
| 分子量 | |
| CAS 号 | |
| 储存方式 | Please store the product under the recommended conditions in the Certificate of Analysis. |
m.cnreagent.com